| scholarly article | Q13442814 |
| P50 | author | Henrik Løvendahl Jørgensen | Q71065309 |
| P2093 | author name string | Nina Skavlan Godtfredsen | |
| Nina H Bjarnason | |||
| Anne S Laulund | |||
| Frederikke K Lomholt | |||
| P2860 | cites work | Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease | Q84300193 |
| Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 | ||
| Health-related quality of life is related to COPD disease severity | Q24814864 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q27860647 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study | Q33483732 | ||
| Statistics notes. The odds ratio | Q33817703 | ||
| Pharmacoeconomic evaluation of COPD. | Q34085273 | ||
| Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation | Q34560346 | ||
| Epidemiology and costs of chronic obstructive pulmonary disease. | Q34563833 | ||
| Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey | Q34967791 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study | Q36391975 | ||
| Mortality in COPD: Role of comorbidities. | Q36670236 | ||
| Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease | Q36723445 | ||
| Global burden of COPD: risk factors, prevalence, and future trends | Q36926621 | ||
| Meta-analysis: Its strengths and limitations. | Q37205285 | ||
| State of the art: using natriuretic peptide levels in clinical practice | Q37257460 | ||
| Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents. | Q37776589 | ||
| Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials | Q37875395 | ||
| Anaemia in chronic obstructive pulmonary disease. Does it really matter? | Q38107279 | ||
| Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases | Q38132484 | ||
| Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor | Q39592306 | ||
| Costs of chronic bronchitis and COPD: a 1-year follow-up study | Q40601070 | ||
| High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. | Q43918982 | ||
| Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure | Q44372363 | ||
| C-reactive protein levels and survival in patients with moderate to very severe COPD. | Q44580491 | ||
| Factors affecting survival of hospitalised patients with COPD. | Q47754437 | ||
| Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department | Q48375065 | ||
| Unrecognised ventricular dysfunction in COPD. | Q49133062 | ||
| Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. | Q51159286 | ||
| Blood transfusion facilitating difficult weaning from the ventilator. | Q51526476 | ||
| Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease | Q77585348 | ||
| Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? | Q79225770 | ||
| Haemoglobin level and its clinical impact in a cohort of patients with COPD | Q79654386 | ||
| Anemia is a mortality predictor in hospitalized patients for COPD exacerbation | Q83502307 | ||
| Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD | Q83808499 | ||
| P577 | publication date | 2014-06-05 | |
| P1433 | published in | European clinical respiratory journal | Q27726792 |
| P1476 | title | Meta-analysis of routine blood tests as predictors of mortality in COPD. | |
| P478 | volume | 1 |
| Q98571581 | Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis |
| Q64077552 | COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power |
| Q92059888 | High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD |
| Q89304880 | N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) |
| Q37397828 | Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. |
| Q55363223 | Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD. |
| Q36646206 | The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life |
Search more.